Answer
Jan 22, 2026 - 01:03 PM
Bimzelx (bimekizumab) is a monoclonal antibody that works by selectively blocking two inflammatory proteins, interleukin-17A (IL-17A) and interleukin-17F (IL-17F). By inhibiting these proteins, Bimzelx reduces inflammation and helps improve symptoms in conditions like plaque psoriasis.
